BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 30862046)

  • 1. Metabolomics Characterizes the Effects and Mechanisms of Quercetin in Nonalcoholic Fatty Liver Disease Development.
    Xu Y; Han J; Dong J; Fan X; Cai Y; Li J; Wang T; Zhou J; Shang J
    Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30862046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mass-Spectrometry-Based Serum Metabolomics of a C57BL/6J Mouse Model of High-Fat-Diet-Induced Non-alcoholic Fatty Liver Disease Development.
    Lai YS; Chen WC; Kuo TC; Ho CT; Kuo CH; Tseng YJ; Lu KH; Lin SH; Panyod S; Sheen LY
    J Agric Food Chem; 2015 Sep; 63(35):7873-84. PubMed ID: 26262841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isoquercetin Improves Hepatic Lipid Accumulation by Activating AMPK Pathway and Suppressing TGF-β Signaling on an HFD-Induced Nonalcoholic Fatty Liver Disease Rat Model.
    Qin G; Ma J; Huang Q; Yin H; Han J; Li M; Deng Y; Wang B; Hassan W; Shang J
    Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30572631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation.
    Porras D; Nistal E; Martínez-Flórez S; Pisonero-Vaquero S; Olcoz JL; Jover R; González-Gallego J; García-Mediavilla MV; Sánchez-Campos S
    Free Radic Biol Med; 2017 Jan; 102():188-202. PubMed ID: 27890642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isobaric tags for relative and absolute quantitation (iTRAQ)-based proteomics for the investigation of the effect of Hugan Qingzhi on non-alcoholic fatty liver disease in rats.
    Yao X; Xia F; Tang W; Xiao C; Yang M; Zhou B
    J Ethnopharmacol; 2018 Feb; 212():208-215. PubMed ID: 29031784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondrial metabolomic profiling for elucidating the alleviating potential of
    Yang XX; Wei JD; Mu JK; Liu X; Li FJ; Li YQ; Gu W; Li JP; Yu J
    World J Gastroenterol; 2019 Nov; 25(43):6404-6415. PubMed ID: 31798277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sesamin ameliorates hepatic steatosis and inflammation in rats on a high-fat diet via LXRα and PPARα.
    Zhang R; Yu Y; Hu S; Zhang J; Yang H; Han B; Cheng Y; Luo X
    Nutr Res; 2016 Sep; 36(9):1022-1030. PubMed ID: 27632923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beneficial effects of paeoniflorin on non-alcoholic fatty liver disease induced by high-fat diet in rats.
    Ma Z; Chu L; Liu H; Wang W; Li J; Yao W; Yi J; Gao Y
    Sci Rep; 2017 Mar; 7():44819. PubMed ID: 28300221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Untargeted serum metabolites profiling in high-fat diet mice supplemented with enhanced palm tocotrienol-rich fraction using UHPLC-MS.
    Goon DE; Ab-Rahim S; Mohd Sakri AH; Mazlan M; Tan JK; Abdul Aziz M; Mohd Noor N; Ibrahim E; Sheikh Abdul Kadir SH
    Sci Rep; 2021 Oct; 11(1):21001. PubMed ID: 34697380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Shenling Baizhu powder alleviates non-alcoholic fatty liver disease by modulating autophagy and energy metabolism in high-fat diet-induced rats.
    Pan M; Deng Y; Qiu Y; Pi D; Zheng C; Liang Z; Zhen J; Fan W; Song Q; Pan J; Li Y; Yan H; Yang Q; Zhang Y
    Phytomedicine; 2024 Jul; 130():155712. PubMed ID: 38763008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study on the mechanism of vitamin E alleviating non-alcoholic fatty liver function based on non-targeted metabolomics analysis in rats.
    Zhao B; Zhang J; Zhao K; Zhao W; Shi Y; Liu J; Zeng L; Wang C; Zeng X; Shi J
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Jun; 397(6):4299-4307. PubMed ID: 38091076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolomic characteristics of cholesterol-induced non-obese nonalcoholic fatty liver disease in mice.
    Tu LN; Showalter MR; Cajka T; Fan S; Pillai VV; Fiehn O; Selvaraj V
    Sci Rep; 2017 Jul; 7(1):6120. PubMed ID: 28733574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quercetin ameliorates dysregulation of lipid metabolism genes via the PI3K/AKT pathway in a diet-induced mouse model of nonalcoholic fatty liver disease.
    Pisonero-Vaquero S; Martínez-Ferreras Á; García-Mediavilla MV; Martínez-Flórez S; Fernández A; Benet M; Olcoz JL; Jover R; González-Gallego J; Sánchez-Campos S
    Mol Nutr Food Res; 2015 May; 59(5):879-93. PubMed ID: 25712622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Angiogenesis Inhibitor ALS-L1023 from Lemon-Balm Leaves Attenuates High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease through Regulating the Visceral Adipose-Tissue Function.
    Kim J; Lee H; Lim J; Oh J; Shin SS; Yoon M
    Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28420164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gallic acid ameliorated impaired glucose and lipid homeostasis in high fat diet-induced NAFLD mice.
    Chao J; Huo TI; Cheng HY; Tsai JC; Liao JW; Lee MS; Qin XM; Hsieh MT; Pao LH; Peng WH
    PLoS One; 2014; 9(2):e96969. PubMed ID: 24918580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolomic analysis shows differential hepatic effects of T
    Iannucci LF; Cioffi F; Senese R; Goglia F; Lanni A; Yen PM; Sinha RA
    Sci Rep; 2017 May; 7(1):2023. PubMed ID: 28515456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quercetin improves nonalcoholic fatty liver by ameliorating inflammation, oxidative stress, and lipid metabolism in db/db mice.
    Yang H; Yang T; Heng C; Zhou Y; Jiang Z; Qian X; Du L; Mao S; Yin X; Lu Q
    Phytother Res; 2019 Dec; 33(12):3140-3152. PubMed ID: 31452288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene-metabolite network analysis in different nonalcoholic fatty liver disease phenotypes.
    Liu XL; Ming YN; Zhang JY; Chen XY; Zeng MD; Mao YM
    Exp Mol Med; 2017 Jan; 49(1):e283. PubMed ID: 28082742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Untargeted metabonomics reveals intervention effects of chicory polysaccharide in a rat model of non-alcoholic fatty liver disease.
    Zhu H; Wang Z; Wu Y; Jiang H; Zhou F; Xie X; Wang R; Hua C
    Int J Biol Macromol; 2019 May; 128():363-375. PubMed ID: 30690116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Silybin ameliorates hepatic lipid accumulation and modulates global metabolism in an NAFLD mouse model.
    Sun R; Xu D; Wei Q; Zhang B; Aa J; Wang G; Xie Y
    Biomed Pharmacother; 2020 Mar; 123():109721. PubMed ID: 31865143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.